Abstracts from 2014 through the most recent CROI can be viewed in this searchable database once they have been presented at the conference. Abstract Contents: The searchable database includes abstract text as submitted by the authors prior to CROI. Study data might be updated during the presentation at CROI. Please refer to the electronic poster or webcast for updates. Searching the Abstract Database: Enter the criteria below and click the “Search” button. After the search has been entered, the results will appear below the search form.

CROI conference materials (eg, the conference program, Abstract eBook, electronic posters, CROI logo, etc) are protected by copyright. Permission to replicate or reproduce these elements, in whole or in part, must be obtained from the CROI Conference Manager, the International Antiviral Society-USA (IAS-USA). Study data (including figures within abstracts or electronic posters) are the property of the study authors. Permission to use data and figures cannot be given by IAS–USA unless it is for regulatory reasons. For more information, please email CROIabstracts@iasusa.org.

Search Results

1277 Results

872 – Mitochondrial DNA Variation and Physical Function Among Men With and Without HIV

Background Mitochondrial DNA variation is associated with multiple aging-related comorbidities among people with HIV (PWH). Data on the effect of inherited mitochondrial DNA variants on physical function among PWH are limited. Methods We included men with ≥2 visits from the Multicenter AIDS Cohort Study. Gait speed and grip strength were evaluated twice annually using standard methods…

877 – Statins Reduce Frailty in People With HIV

Background Statins have pleiotropic effects beyond lowering LDL cholesterol, offering benefits in multiple cardiometabolic conditions and reducing chronic inflammation. These effects have the potential to also influence biological aging trajectories, reflected by frailty. The objective of this study was to compare frailty trajectories, in people with HIV (PWH) who used statins for primary cardiovascular prevention…

855 – APOL1 Genotype and Graft Function in South African HIV+-to-HIV+ Kidney Transplant Recipients

Background APOL1 gene risk variants (G1: S342G and I384M; and G2: del N388 and Y389) significantly contribute to genetic risk of chronic kidney disease (CKD), particularly in people living with HIV (PLWH). Shorter renal allograft survival has been demonstrated in kidney transplant recipients (KTR) without HIV where either donor or recipient kidney genotype included a…

865 – The Projected Impact of Post-ART BMI Maintenance on Diabetes Risk: A Modeling Study

Background Weight gain following ART initiation has been linked to an increased risk of diabetes among persons aging with HIV (PAH). We aimed to assess the impact of a hypothetical BMI maintenance program, implemented in the first 2 years after ART initiation, on cumulative diabetes risk over 7 years post-ART initiation. Methods The PEARL model…

880 – Housing Instability and Frailty Among People With HIV Engaged in Clinical Care in the United States

Background Living with HIV infection and experiencing housing instability are both independently associated with early onset of aging-related comorbidities including frailty. However, few studies have examined the relationship between housing status and frailty among people with HIV (PWH). Methods We analyzed data from PWH engaged in care at 6 sites across the US within the…

879 – Clinical and Economic Benefits of Preventing Physical Frailty and Falls Among PWH in the US

Background Over 50% of people with HIV (PWH) in the United States (US) are older than 50 years and are at risk for a high lifetime burden of physical frailty, falls, and fall-related fractures. However, data on the long-term clinical and economic consequences of these events are sparse. We projected the survival gains and economic…

916 – Safety of Full-Spectrum Cannabidiol for PWH: A Double-Blind, Randomized, Placebo-Controlled Study

Background People with long-term controlled HIV (PWH) suffer from inflammaging, characterized by chronic inflammation and immunosenescence. As cannabis smokers display immune beneficial effects such as lower levels of inflammation and as the popularity of cannabidiol (CBD) products increases, we evaluated the safety of a full-spectrum cannabidiol drug for the first time on PWH. The new results presented herein…

804 – Low-Level HIV Viremia Increases Immunosuppressive Markers Elevating Cancer and CVD Risk in InSTI Era

Background We previously reported that low-level viremia (LLV) (50-200 copies/mL) increases cellular activation and senescence in people with HIV (PWH), phenomena closely related to the development of cancer and cardiovascular diseases (CVD). However, data on the clinical consequences of LLV remain limited, especially in the integrase strand transfer inhibitors (INSTI) era. Our aim was to explore…

911 – Disparities in Hospitalization Among People in the HIV Outpatient Study, United States, 2008-2022

Background Hospitalization rates are an important clinical indicator to monitor treatment effectiveness and the complications of antiretroviral therapy and advanced HIV disease, and provide an endpoint for morbidity among people with HIV (PWH).  We examined sociodemographic and clinical disparities in hospitalization rates among PWH in the HIV Outpatient Study (HOPS), a demographically diverse, multi-city cohort…

875 – Muscular Markers for Early Identification of Sarcopenia and Frailty States in Older People With HIV

Background Considering the critical need to identify people with HIV (PWH) at risk of frailty and sarcopenia, we present the results of the Functional substudy of the IMAGING study, a study aimed to identify image aging markers by whole-body magnetic resonance imaging (WB-MRI) in 50 PWH aged 50 years or older and 25 matched controls. Methods…